B Leonard Holman

Title: B Leonard Holman: Innovator in Radiopharmaceuticals

Introduction

B Leonard Holman is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of radiopharmaceuticals, particularly with his innovative patent that focuses on tantalum-178.

Latest Patents

Holman's most recent patent is titled "Radiopharmaceutical composition containing tantalum-178 and process." This patent describes a physiologically acceptable solution of tantalum-178, which has an activity ranging from 0.1 to 200 millicuries per milliliter. The solution is derived from tungsten-178, which is bound to a column of an anion exchange resin. Tantalum-178 is formed in situ by eluting the column with a hydrochloric acid solution that contains hydrogen peroxide, resulting in an acidic solution of tantalum-178. This acidic solution is then neutralized for use.

Career Highlights

Holman is affiliated with the Massachusetts Institute of Technology, where he continues to engage in research and development in the field of radiopharmaceuticals. His work has implications for medical applications, particularly in diagnostics and treatment.

Collaborations

Some of his notable coworkers include Rudi D Neirinckx and Michael A Davis. Their collaborative efforts contribute to advancements in the field of radiopharmaceuticals.

Conclusion

B Leonard Holman is a distinguished inventor whose work in radiopharmaceuticals has the potential to impact medical science significantly. His innovative approach to tantalum-178 solutions showcases the importance of research in developing new medical technologies.